Development and implementation of a mindfulness-based intervention (REMIND2.0) for people in recovery in Hong Kong: the exploratory pilot randomised controlled trial

Hong Kong Baptist University0 个研究点目标入组 28 人开始时间: 2022年7月19日最近更新: 2022年8月5日

适应症

试验速览

暂无简介。

•1. Aged 18 years or above
•2. Permanent Hong Kong residents
•3. Diagnosed with mental illness with standardised diagnostic criteria, such as the Classification of Diseases (11th ed.; ICD-11; World Health Organization, 2018) or Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5; American Psychiatric Association, 2013), for any length of illness
•4. Capable of providing informed consent to participate in the trial; (v) able to understand Chinese languages to engage in the intervention or to complete written assessment in Chinese; and
•5. A service user from the community-based mental health service

•1. Established diagnosis of learning disability or major cognitive impairment arising from any underlying medical condition resulting in significant functional impairment
•2. Primary diagnosis of substance abuse, as substance use may increase and/or trigger symptoms of mental illnesses, and hence it has different trajectories from other mental illnesses
•3. Mental state that precludes the possibility of engaging in the intervention (e.g. significant thought disorder)
•4. Engagement in concurrent mindfulness intervention
•5. Do not provide informed consent
•6. Refused to be randomised

发起方